RSS

Lonza

EPM editor Reece Armstrong caught up with Frederique Bordes-Picard, business development for innovative products capsule delivery solutions at Lonza to learn more about the company's new dry-powder inhalation capsule. Read more

Opinion

Biotechnology company Lonza has announced it is to purchase a sterile drug product fill & finish facility from major pharma player Novartis. Read more

News

Contract development manufacturing organisation (CDMO) Lonza is expanding its highly potent API (HPAPI) capacity in order to meet increased market demand. Read more

News

Stéphane Varray - commercial development - head of Launch for Mammalian and Microbial, Development & Manufacturing at Lonza discusses trends in biomanufacturing and the innovation occurring in the sector. Read more

Opinion

Biotechnology company Lonza has launched a new portfolio for dry-powder inhalation (DPI) capsules, the company has announced. Read more

News

Major pharma player Lonza has launched an integrated service to help address bioavailability challenges with drug substance, solid-state characterisation and drug product for first-in-human studies. Read more

News

Bioscience company Chr. Hansen and contract manufacturer Lonza have signed a joint venture in an aim to position themselves as the leading contract development and manufacturing partner (CDMO) in the industry. Read more

News

Lonza has expanded its footprint for parenteral dosage form development by investing in its Drug Product Services (DPS) site, the company has announced. Read more

News

Sven Stegemann, director of pharmaceutical business development, Lonza Pharma & Biotech, discusses how using sprinkle formulation technology helps manufacturers focus on the patient in medicine development. Read more

Opinion

Biotechnology company Lonza has announced an initiative with GE Healthcare in which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou, China (CN). Read more

News

Swiss multinational, Lonza Pharma & Biotech has opened its Collaborative Innovation Centre (CIC) in Israel to help accelerate new therapies and manufacturing practices. Read more

News

Capsule Delivery Solutions has launched a new capsule based on an “allcolorants” formulation, helping Lonza Capsugel expand its R&D offering. Read more

News

Alyn McNaughton, technical director for Lonza Edinburgh, Lonza Pharma & Biotech discusses the requirements and regulations surrounding serialisation legislation. Read more

Opinion

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

Integrated solutions provider — Lonza — has announced the launch of a new bioscience website, designed to support the work of scientists across the bioresearch, drug discovery and pharmaceutical manufacturing fields. Read more

Technology

A Master Service Agreement has been entered by TxCell and Lonza Pharma & Biotech for the manufacture of a CAR-Treg cellular product (TX200), which is in development for the prevention of chronic rejection after organ transplantation. Read more

News

A long-term contract extension has been agreed by Proteon Therapeutics and Lonza Pharma & Biotech for the commercial supply of the investigational vonapanitase’s active pharmaceutical ingredient (API). Read more

News

Lonza Pharma & Biotech has invested in a new phase of development at its Portsmouth, New Hampshire, USA site, which will include mid-scale mammalian capacity and the addition of new cell-therapy suites. Read more

News

Integrated solutions provider, Lonza, has opened a dedicated cell-and-gene-therapy facility with the capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases. Read more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News